Novo Nordisk Hikes Forecasts on Robust Wegovy Sales

Strong first-quarter sales, particularly from its Wegovy pill, led pharmaceutical giant Novo Nordisk to significantly raise its financial guidance. The company's performance exceeded expectations following Wegovy's market launch.

6 May, 06:46 — 6 May, 06:46

Post Share

Sources

Showing 1 of 2 sources

cnbcMostly Factual16m ago

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

Read full article →

Coverage Timeline

First report: berlingske · 6 May, 05:39|Full coverage: 2 · 1h|Window: 1h

Left-leaningCenterRight-leaning

berlingske6 May, 05:39First to report

Novo Nordisks salg stiger i første kvartal

1h later

cnbc6 May, 06:46Latest update

PERSPECTA

PERSPECTA

Novo Nordisk Hikes Forecasts on Robust Wegovy Sales

Sources

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Coverage Timeline

Novo Nordisks salg stiger i første kvartal

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Global Oil Prices Surge; Norway Reopens North Sea Fields

Kwankwaso Meets NDC Chair to Resolve Kano Crisis

Latvian Competition Council Fines Three Companies Over Half a Million Euros for Price Fixing

PERSPECTA